Key facts
- This page summarizes Serge Saxonov's Form 4 filing for 10x Genomics, Inc. (TXG).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 13 Nov 2026, 16:53.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
No transaction description listed
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
The Reporting Person contributed the shares to an exchange fund in exchange for shares of the exchange fund. The shares were valued at $62.90 per share for the purpose of determining the number of shares of the exchange fund issuable to the Reporting Person.
Footnote F2
The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
Footnote F3
The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
Footnote F4
The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.